Renal Denervation in the Treatment of Resistant Hypertension and Difficult-to-Control Hypertension – Consensus Document of the Croatian Hypertension League – Croatian Society of Hypertension, Croatian Cardiac Society, Croatian Endovascular Initiative, Croatian Society for Diabetes and Metabolic Diseases, Croatian Renal Association, and Croatian Society of Family Physicians of the Croatian Medical Association

References

• Williams B, Mancia G, Spiering W; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
   PubMed Web of Science ®Google Scholar
• The Task Force for the management of arterial hypertension of the European Society of Hypertension. 2023 ESH Guidelines for the management of arterial hypertension. Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hyperten. 2023;41:1.
   PubMedGoogle Scholar
• Chia R, Pandey A, Vongpatanasin W. Resistant hypertension-defining the scope of the problem. Prog Cardiovasc Dis. 2020;63(1):46–50. doi:10.1016/j.pcad.2019.12.006
   PubMed Web of Science ®Google Scholar
• Noubiap JJ, Nansseu JR, Nyaga UF, Sime PS, Francis I, Bigna JJ. Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients. Heart. 2019;105(2):98–105. doi:10.1136/heartjnl-2018-313599
   PubMed Web of Science ®Google Scholar
• Jelaković B, Kuzmanić D, Laganović M. Epidemiologija arterijske hipertenzije u Hrvatskoj EH-UH 2000 Epidemiology of arterial hypertension in Croatia EH-UH 2000. Lijec Vjesn. 2001;123(11–12):334–336.
   PubMedGoogle Scholar
• Erceg M, Knežević A M. Izvješće o umrlim osobama u Hrvatskoj u 2020. godini [Report on mortality in Croatia, 2020]. HZJZ; 2020. Available from: https://www.hzjz.hr/wpcontent/uploads/2021/10/Bilten_Umrli-_2020.pdf. Accessed November 22, 2023.
   Google Scholar
• Bhatt DL, Kandzari DE, O’Neill WW, et al. SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393–1401. doi:10.1056/NEJMoa1402670
   PubMed Web of Science ®Google Scholar
• Kandzari DE, Bhatt DL, Brar S, et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J. 2015;36:219–227. doi:10.1093/eurheartj/ehu441
   PubMed Web of Science ®Google Scholar
• Townsend RR, Mahfoud F, Kandzari DE, et al. SPYRAL HTN-OFF MED trial investigators. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390(10108):2160–2170. doi:10.1016/S0140-6736(17)32281-X
   PubMed Web of Science ®Google Scholar
• Kandzari DE, Böhm M, Mahfoud F, et al. SPYRAL HTN-ON MED Trial Investigators. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018;391(10137):2346–2355. doi:10.1016/S0140-6736(18)30951-6
   PubMed Web of Science ®Google Scholar
• Böhm M, Kario K, Kandzari DE, et al. SPYRAL HTN-OFF MED Pivotal Investigators. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395(10234):1444–1451. doi:10.1016/S0140-6736(20)30554-7
   PubMed Web of Science ®Google Scholar
• Azizi M, Schmieder RE, Mahfoud F, et al. RADIANCE-HTN Investigators. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018;391(10137):2335–2345. doi:10.1016/S0140-6736(18)31082-1
   PubMed Web of Science ®Google Scholar
• Azizi M, Sanghvi K, Saxena M, et al. RADIANCE-HTN investigators. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet. 2021;397(10293):2476–2486. doi:10.1016/S0140-6736(21)00788-1
   PubMed Web of Science ®Google Scholar
• Azizi M, Pereira H, Hamdidouche I, et al. DENERHTN Investigators. Adherence to antihypertensive treatment and the blood pressure-lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial. Circulation. 2016;134(12):847–857. doi:10.1161/CIRCULATIONAHA.116.022922
   PubMed Web of Science ®Google Scholar
• Chow CK, Teo KK, Rangarajan S, et al. PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–968. doi:10.1001/jama.2013.184182
   PubMed Web of Science ®Google Scholar
• Kario K, Hoshide S, Mizuno H, et al.; JAMP Study Group. Nighttime blood pressure phenotype and CV prognosis: practitioner-based nationwide JAMP study. Circulation. 2020;142(19):1810–1820. doi:10.1161/CIRCULATIONAHA.120.049730
   PubMed Web of Science ®Google Scholar
• Kario K, Weber MA, Böhm M, et al. Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial. Clin Res Cardiol. 2021;110(5):725–731. doi:10.1007/s00392-020-01718-6
   PubMed Web of Science ®Google Scholar
• Ahmad Y, Francis DP, Bhatt DL, Howard JP. Renal denervation for hypertension: a systematic review and meta-analysis of randomized, blinded, placebo-controlled trials. Cardiovasc Interv. 2021;14(23):2614–2624. doi:10.1016/j.jcin.2021.09.020
   PubMed Web of Science ®Google Scholar
• Kordalis A, Tsiachris D, Pietri P, Tsioufis C, Stefanadis C. Regression of organ damage following renal denervation in resistant hypertension: a meta-analysis. J Hypertens. 2018;36(8):1614–1621. doi:10.1097/HJH.0000000000001798
   PubMed Web of Science ®Google Scholar
• Kandzari DE, Mahfoud F, Weber MA, et al. Clinical trial design principles and outcomes definitions for device-based therapies for hypertension: a consensus document from the hypertension academic research consortium. Circulation. 2022;145(11):847–863. doi:10.1161/CIRCULATIONAHA.121.057687
   PubMed Web of Science ®Google Scholar
• Jelaković A, Begić Z, Bašić M, et al. Characteristic of responders to renal denervation - Croatian real-life. J of Hypertension. 2023;41(3):p e255. doi:10.1097/01.hjh.0000941612.89148.45
   PubMedGoogle Scholar
• Begić Z, Jelaković A, Bašić M; Symplicity HTN-2 Investigators. High salt intake did not diminish beneficial effect of renal denervation on blood pressure, kidney function and metabolic profile - Croatian real-life study. J Hypertension. 2023;41(suppl 3):e297. doi:10.1097/01.hjh.0000942096.92379.8f
   Google Scholar
• Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376(9756):1903–1909.
   PubMed Web of Science ®Google Scholar
• Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373(9671):1275–1281. doi:10.1016/S0140-6736(09)60566-3
   PubMed Web of Science ®Google Scholar
• Bakris GL, Townsend RR, Liu M, et al. SYMPLICITY HTN-3 Investigators. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol. 2014;64(11):1071–1078. doi:10.1016/j.jacc.2014.05.012
   PubMed Web of Science ®Google Scholar
• Karanasos A, Van Mieghem N, Bergmann M, et al. Multimodality intra-arterial imaging assessment of the vascular trauma induced by balloon-based and nonballoon-based renal denervation systems. Circ Cardiovasc Interv. 2015;8(7):e002474. doi:10.1161/CIRCINTERVENTIONS.115.002474
   PubMed Web of Science ®Google Scholar
• Kandzari DE, Bhatt DL, Sobotka PA, et al. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol. 2012;35(9):528–535. doi:10.1002/clc.22008
   PubMed Web of Science ®Google Scholar
• Peters CD, Mathiassen ON, Vase H, et al. The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial). Blood Press. 2017;26(6):366–380. doi:10.1080/08037051.2017.1368368
   PubMed Web of Science ®Google Scholar
• Rousselle D, Brants I, Sakaoka A, et al. Neuromatous regeneration as a nerve response after catheter-based renal denervation therapy in a large animal model: immunohistochemical study. Circ Cardiovasc Interv. 2015;8(5):e002293. doi:10.1161/CIRCINTERVENTIONS.114.002293
   PubMed Web of Science ®Google Scholar
• Booth LC, Nishi EE, Yao ST, et al. Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep. Hypertension. 2015;65:393–400. doi:10.1161/HYPERTENSIONAHA.114.04176
   PubMed Web of Science ®Google Scholar
• Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol. 2011;100(12):1095–1101. doi:10.1007/s00392-011-0346-8
   PubMed Web of Science ®Google Scholar
• Cohen-Mazor M, Mathur P, Stanley JR, et al. Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model. J Hypertens. 2014;32(8):1678–1691. doi:10.1097/HJH.0000000000000236
   PubMed Web of Science ®Google Scholar
• Gazdar AF, Dammin GJ. Neural degeneration and regeneration in human renal transplants. N Engl J Med. 1970;283(5):222–224. doi:10.1056/NEJM197007302830502
   PubMed Web of Science ®Google Scholar
• Norvell JE, Weitsen HA, Sheppek CG. The intrinsic innervation of human renal homotransplants. Transplantation. 1970;9(2):168–176. doi:10.1097/00007890-197002000-00020
   PubMed Web of Science ®Google Scholar
• Mauriello A, Rovella V, Borri F, et al. Hypertension in kidney transplantation is associated with an early renal nerve sprouting. Nephrol Dial Transplant. 2017;32(6):1053–1060. doi:10.1093/ndt/gfx069
   PubMed Web of Science ®Google Scholar
• Hansen JM, Abildgaard U, Fogh-Andersen N, et al. The transplanted human kidney does not achieve functional reinnervation. Clin Sci. 1994;87(1):13–20. doi:10.1042/cs0870013
   Web of Science ®Google Scholar
• Katsurada K, Kario K. Emerging topics on renal denervation in hypertension: anatomical and functional aspects of renal nerves. Hypertens Res. 2023;46(6):1462–1470. doi:10.1038/s41440-023-01266-2
   PubMed Web of Science ®Google Scholar
• Williams B, MacDonald TM, Morant SV, et al. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies. Lancet Diabetes Endocrinol. 2018;6:464–475. doi:10.1016/S2213-8587(18)30071-8
   PubMed Web of Science ®Google Scholar
• Kairo K, Kagitani H, Hayashi S, Hanamura S, Ozawa K, Kanegae H. A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment. Hypertens Res. 2022;45(2):232–240. doi:10.1038/s41440-021-00760-9
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Högerl K, Jung S, Bramlage P, Veelken R, Ott C. Patient preference for therapies in hypertension: a cross-sectional survey of German patients. Clin Res Cardiol. 2019;108:1331–1342. doi:10.1007/s00392-019-01468-0
   PubMed Web of Science ®Google Scholar
• Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):136–143. doi:10.1513/pats.200709-155MG
   PubMedGoogle Scholar
• Kario K, Bhatt DL, Kandzari DE, et al. Impact of renal denervation on patients with obstructive sleep apnea and resistant hypertension- insights from the SYMPLICITY HTN-3 trial. Circ J. 2016;80(6):1404–1412. doi:10.1253/circj.CJ-16-0035
   PubMed Web of Science ®Google Scholar
• Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58(4):559–565. doi:10.1161/HYPERTENSIONAHA.111.173799
   PubMed Web of Science ®Google Scholar
• Fay KS, Cohen DL. Resistant hypertension in subjects with CKD: a review. Am J Kidney Dis. 2021;77(1):110–121. doi:10.1053/j.ajkd.2020.04.017
   PubMed Web of Science ®Google Scholar
• Burnier M. Renal denervation for patients with CKD and resistant hypertension: effective and safe but still not the panacea. Nephrol Dial Transplant. 2022;37(2):208–210. doi:10.1093/ndt/gfab208
   PubMed Web of Science ®Google Scholar
• DiBona GF. Neural control of the kidney: functionally specific renal sympathetic nerve fibers. Am J Physiol Regul Integr Comp Physiol. 2000;279(5):R1517–R1524. doi:10.1152/ajpregu.2000.279.5.R1517
   PubMed Web of Science ®Google Scholar
• Quarti-Trevano F, Seravalle G, Dell’Oro R, Mancia G, Grassi G. Autonomic CV Alterations in CKD: effects of dialysis, kidney transplantation, and renal denervation. Curr Hypertens Rep. 2021;23(2):10. doi:10.1007/s11906-021-01129-6
   PubMed Web of Science ®Google Scholar
• Grassi G, Quarti-Trevano F, Seravalle G, et al. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension. 2011;57(4):846–851. doi:10.1161/HYPERTENSIONAHA.110.164780
   PubMed Web of Science ®Google Scholar
• Converse RL, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327(27):1912–1918. doi:10.1056/NEJM199212313272704
   PubMed Web of Science ®Google Scholar
• Hausberg M, Kosch M, Harmelink P, et al. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106(15):1974–1979. doi:10.1161/01.CIR.0000034043.16664.96
   PubMed Web of Science ®Google Scholar
• Koomans HA, Blankestijn PJ, Joles JA. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol. 2004;15(3):524–537. doi:10.1097/01.ASN.0000113320.57127.B9
   PubMed Web of Science ®Google Scholar
• Hering D, Mahfoud F, Walton AS, et al. Renal denervation in moderate to severe CKD. J Am Soc Nephrol. 2012;23(7):1250–1257. doi:10.1681/ASN.2011111062
   PubMed Web of Science ®Google Scholar
• Ott C, Mahfoud F, Schmid A, et al. Renal denervation preserves renal function in patients with CKD and resistant hypertension. J Hypertens. 2015;33(6):1261–1266. doi:10.1097/HJH.0000000000000556
   PubMed Web of Science ®Google Scholar
• Hering D, Marusic P, Duval J, et al. Effect of renal denervation on kidney function in patients with CKD. Int J Cardiol. 2017;232:93–97. doi:10.1016/j.ijcard.2017.01.047
   PubMed Web of Science ®Google Scholar
• Ott C, Mahfoud F, Mancia G, et al. Renal denervation in patients with versus without CKD: results from the Global SYMPLICITY Registry with follow-up data of 3 years. Nephrol Dial Transplant. 2022;37(2):304–310. doi:10.1093/ndt/gfab154
   PubMed Web of Science ®Google Scholar
• Solbu MD, Miroslawska A, Norvik JV, Eriksen BO, Steigen TK. Kidney function and markers of renal damage after renal denervation. Does method of measurement matter? The Reshape CV-Risk Study. J Clin Hypertens. 2021;23(5):954–962. doi:10.1111/jch.14214
   Web of Science ®Google Scholar
• Mahfoud F, Böhm M, Schmieder R, et al. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry. Eur Heart J. 2019;40(42):3474–3482. doi:10.1093/eurheartj/ehz118
   PubMed Web of Science ®Google Scholar
• Marin F, Fezzi S, Gambaro A, et al. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with CKD: first Italian real-world experience. J Nephrol. 2021;34(5):1445–1455. doi:10.1007/s40620-021-00966-7
   PubMed Web of Science ®Google Scholar
• Mahfoud F, Bakris G, Bhatt DL, et al. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. Eur Heart J. 2017;38(2):93–100. doi:10.1093/eurheartj/ehw325
   PubMed Web of Science ®Google Scholar
• Ott C, Mahfoud F, Schmid A, et al. Improvement of albuminuria after renal denervation. Int J Cardiol. 2014;173(2):311–315. doi:10.1016/j.ijcard.2014.03.017
   PubMed Web of Science ®Google Scholar
• Kiuchi MG, Chen S. Improvement of renal function after renal sympathetic denervation in CKD patients with controlled vs. uncontrolled hypertension. Int J Cardiol. 2016;223:494–496. doi:10.1016/j.ijcard.2016.08.262
   PubMed Web of Science ®Google Scholar
• Sanders MF, Reitsma JB, Morpey M, et al. Renal safety of catheter-based renal denervation: systematic review and meta-analysis. Nephrol Dial Transplant. 2017;32(9):1440–1447. doi:10.1093/ndt/gfx088
   PubMed Web of Science ®Google Scholar
• RDN-CKD Study (RDN-CKD). Renal denervation in chronic kidney disease. Available from: https://classic.clinicaltrials.gov/ct2/show/study/NCT04264403. Accessed November 22, 2023.
   Google Scholar
• Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115(4):291–297. doi:10.1016/S0002-9343(03)00366-8
   PubMed Web of Science ®Google Scholar
• Fan S, Sayed RH, Davenport A. Extracellular volume expansion in peritoneal dialysis patients. Int J Artif Organs. 2012;35(5):338–345. doi:10.5301/ijao.5000080
   PubMed Web of Science ®Google Scholar
• Mauriello A, Rovella V, Anemona L, et al. Increased sympathetic renal innervation in hemodialysis patients is the anatomical substrate of sympathetic hyperactivity in end-stage renal disease. J Am Heart Assoc. 2015;4(12):e002426. doi:10.1161/JAHA.115.002426
   PubMed Web of Science ®Google Scholar
• Schlaich MP, Bart B, Hering D, et al. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol. 2013;168(3):2214–2220. doi:10.1016/j.ijcard.2013.01.218
   PubMed Web of Science ®Google Scholar
• Ott C, Schmid A, Ditting T, Veelken R, Uder M, Schmieder RE. Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience. Clin Exp Nephrol. 2019;23(6):749–755. doi:10.1007/s10157-019-01697-7
   PubMed Web of Science ®Google Scholar
• Scalise F, Sole A, Singh G, et al. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis. J Hypertens. 2020;38(5):936–942. doi:10.1097/HJH.0000000000002358
   PubMed Web of Science ®Google Scholar
• Mahfoud F, Tunev S, Ewen S, et al. Impact of lesion placement on efficacy and safety of catheter-based radiofrequency renal denervation. J Am Coll Cardiol. 2015;66(16):1766–1775. doi:10.1016/j.jacc.2015.08.018
   PubMed Web of Science ®Google Scholar
• Mahfoud F, Pipenhagen CA, Boyce Moon L, et al. Comparison of branch and distally focused main renal artery denervation using two different radio-frequency systems in a porcine model. Int J Cardiol. 2017;241:373–378. doi:10.1016/j.ijcard.2017.04.057
   PubMed Web of Science ®Google Scholar
• Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA. 2000;283(5):633–638. doi:10.1001/jama.283.5.633
   PubMed Web of Science ®Google Scholar
• Schwenger V, Zeier M, Ritz E. Hypertension after renal transplantation. Ann Transplant. 2001;6(4):25–30.
   PubMedGoogle Scholar
• Zhang W, Li JL, Hosaka M, et al. Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci U S A. 2000;97(17):9765–9770. doi:10.1073/pnas.170160397
   PubMed Web of Science ®Google Scholar
• Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med. 1990;323(11):693–699. doi:10.1056/NEJM199009133231101
   PubMed Web of Science ®Google Scholar
• Obremska M, Boratyńska M, Zyśko D, et al. Beneficial effect of bilateral native nephrectomy as complete denervation on left ventricular mass and function in renal transplant recipients. Pol Arch Med Wewn. 2016;126(1–2):58–67. doi:10.20452/pamw.3269
   PubMed Web of Science ®Google Scholar
• Protasiewicz M, Początek K, Banasik M, et al. Successful renal artery denervation in a renal transplant recipient with refractory hypertension. Am J Hypertens. 2014;27(7):982–984. doi:10.1093/ajh/hpt291
   PubMed Web of Science ®Google Scholar
• Dobrowolski LC, Bemelman FJ, Ten Berge IJ, van den Born BJ, Reekers JA, Krediet CT. Renal denervation of the native kidneys for drug-resistant hypertension after kidney transplantation. Clin Kidney J. 2015;8(1):79–81. doi:10.1093/ckj/sfu134
   PubMedGoogle Scholar
• Protasiewicz M, Banasik M, Kurcz J, et al. Renal artery denervation in patient after heart and kidney transplantation with refractory hypertension. Transplant Proc. 2016;48(5):1858–1860. doi:10.1016/j.transproceed.2016.01.043
   PubMed Web of Science ®Google Scholar
• Pietilä-Effati PM, Salmela AK, Koistinen MJ. Intravascular renal denervation in renal dialysis patients with uncontrolled hypertension: a case series of four patients. Am J Case Rep. 2018;19:985–991. doi:10.12659/AJCR.909820
   PubMed Web of Science ®Google Scholar
• Schneider S, Promny D, Sinnecker D, et al. Impact of sympathetic renal denervation: a randomized study in patients after renal transplantation (ISAR-denerve). Nephrol Dial Transplant. 2015;30(11):1928–1936. doi:10.1093/ndt/gfv311
   PubMed Web of Science ®Google Scholar
• Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–221. doi:10.1177/1747493019897870
   PubMed Web of Science ®Google Scholar
• Versaci F, Sciarretta S, Scappaticci M, et al. Renal arteries denervation: from the treatment of resistant hypertension to the treatment of atrial fibrillation. Eur Heart J Suppl. 2021;23(Suppl E):E177–E183. doi:10.1093/eurheartj/suab117
   PubMed Web of Science ®Google Scholar
• Kallistratos MS, Poulimenos LE, Manolis AJ. Atrial fibrillation and arterial hypertension. Pharmacol Res. 2018;128:322–326. doi:10.1016/j.phrs.2017.10.007
   PubMed Web of Science ®Google Scholar
• Mahfoud F, Townsend RR, Kandzari DE, et al. Changes in plasma renin activity after renal artery sympathetic denervation. J Am Coll Cardiol. 2021;77(23):2909–2919. doi:10.1016/j.jacc.2021.04.044
   PubMed Web of Science ®Google Scholar
• Okin PM, Hille DA, Larstorp AC, et al. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients. Hypertension. 2015;66(2):368–373. doi:10.1161/HYPERTENSIONAHA.115.05728
   PubMed Web of Science ®Google Scholar
• Pokushalov E, Romanov A, Corbucci G, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60(13):1163–1170. doi:10.1016/j.jacc.2012.05.036
   PubMed Web of Science ®Google Scholar
• Nawar K, Mohammad A, Johns EJ, Abdulla MH. Renal denervation for atrial fibrillation: a comprehensive updated systematic review and meta-analysis. J Hum Hypertens. 2022;36(10):887–897. doi:10.1038/s41371-022-00658-0
   PubMed Web of Science ®Google Scholar
• Thomas MC, Dublin S, Kaplan RC, et al. Blood pressure control and risk of incident atrial fibrillation. Am J Hypertens. 2008;21(10):1111–1116. doi:10.1038/ajh.2008.248
   PubMed Web of Science ®Google Scholar
• Pokushalov E, Romanov A, Katritsis DG, et al. Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience. Heart Rhythm. 2014;11(7):1131–1138. doi:10.1016/j.hrthm.2014.03.055
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Kardiol Pol. 2016;74(10):1037–1147. doi:10.5603/KP.2016.0141
   PubMed Web of Science ®Google Scholar
• Polhemus DJ, Trivedi RK, Gao J, et al. Renal sympathetic denervation protects the failing heart via inhibition of neprilysin activity in the kidney. J Am Coll Cardiol. 2017;70(17):2139–2153. doi:10.1016/j.jacc.2017.08.056
   PubMed Web of Science ®Google Scholar
• Davies JE, Manisty CH, Petraco R, et al. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol. 2013;162(3):189–192. doi:10.1016/j.ijcard.2012.09.019
   PubMed Web of Science ®Google Scholar
• Brandt MC, Mahfoud F, Reda S, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59(10):901–909. doi:10.1016/j.jacc.2011.11.034
   PubMed Web of Science ®Google Scholar
• Kresoja K, Rommel MK-P, Fengler K, et al. Renal sympathetic denervation in patients with heart failure with preserved ejection fraction. Circ Heart Fail. 2021;14(3):e007421. doi:10.1161/CIRCHEARTFAILURE.120.007421
   PubMed Web of Science ®Google Scholar
• Li M, Ma W, Fan F, et al. Renal denervation in management of heart failure with reduced ejection fraction: a systematic review and meta-analysis. J Cardiol. 2023;81(6):513–521. doi:10.1016/j.jjcc.2023.01.010
   PubMed Web of Science ®Google Scholar